Kyndryl Holdings Inc vs Sana Biotechnology Inc — how do they compare? Kyndryl Holdings Inc trades at $12.19 (market cap $2.69B), while Sana Biotechnology Inc trades at $3.17 (market cap $873.84M). The key difference: Kyndryl Holdings Inc is far larger — about 3.1× Sana Biotechnology Inc's market cap. Which is the better fit depends on your goals.
| KD | SANA | |
|---|---|---|
Market Cap | $2.69B | $873.84M |
Sector | Technology | Health |
52-Week High | $39.47 | $5.92 |
52-Week Low | $10.59 | $2.68 |
Enterprise Value | $5.03B | $848.03M |
Trailing returns across standard periods
Latest headlines on both assets
Kyndryl Holdings Inc is a technology services and infrastructure services provider company. It provides advisory, implementation, and managed services across a range of technology domains to help customers manage and modernize enterprise IT environments in support of their business and transformation objectives.
Read more on KD →Sana Biotechnology Inc. is a clinical-stage biopharmaceutical company focused on creating and delivering engineered cells as medicines for patients. The company is developing cell therapies for various diseases, including oncology, diabetes, and central nervous system disorders. Sana's core strategy is built around two key technological platforms: in vivo gene delivery to repair cells inside the body and ex vivo cell engineering for therapeutic use.
Read more on SANA →